Cat scratch disease (CSD) has been difficult to diagnose in animals because of the protracted clinical course of infection and the quiescent phases when the microbial culprit lies dormant. The causative agent in CSD appears to be multiple species and strains of Bartonella. Using polymerase chain reaction (PCR) techniques for amplification of highly variable regions of the 16S ribosomal RNA (rRNA) gene sequence, a very sensitive species-and strain-specific assay for CSD-causing Bartonella species was developed. PCR primers were designed to specifically amplify the 16S rRNA gene of Bartonella species but not of other microbial pathogens. This initial PCR was multiplexed with a universal primer set, based on conserved sequence regions in the 16S rRNA gene, that provides a 162-bp fragment in all species tested. Subsequently, 3 distinct nested PCR primer sets enabled the individual amplification and specific detection of Bartonella henselae type I, B. henselae type II, and B. clarridgeae. Thus, this 2-step PCR procedure enabled the sensitive detection and identification of these species and the B. henselae genotype by exploiting minor sequences differences. Verification of these results were demonstrated with both sequencing and ligase chain reaction techniques. The diagnostic usefulness of this CSD test has been demonstrated by the analysis of specimens from control and infected cats. The diagnosis was confirmed and the specific B. henselae strain was correctly identified in peripheral blood specimens obtained from control and strain-specific CSD-infected cats. Such an accurate and sensitive diagnostic tool for the detection and identification of CSD causative agents should be a useful for the medical, veterinary, and scientific communities.
Cat scratch disease (CSD) in animals and humans appears to be caused most frequently by infection with Bartonella henselae. 12, 18 Other causes of infection have been identified in animal clinics and human specimens, including B. clarridgeiae, B. quintana, B. elizabethae, and B. vinsonii. 7, 12, 14 It is not clear whether B. henselae is the only species to produce CSD in humans. However, the Bartonella species are known to be pathogenic and to produce a wide variety of clinical signs in both animals and humans, including hemolytic anemia, endocarditis, osteomyelitis, bacilliary angiomatosis, myositis, retinitis, encephalopathy, and lymphadenopathy. 12 The detection and identification of any of the Bartonella species in cats and dogs is important to the veterinary care of these animals.
Until recently, laboratory diagnosis of CSD relied on serologic testing and bacterial culture isolation methods. 1 However, laboratory detection and verification of CSD by culture has been difficult because of the characteristics of systemic infections caused by these microbial species, including slow growth, intracellular masking, and a quiescent state or dormant pe-riod. 1, 13, 16 Inconsistencies have also been reported for serologic testing in the use of antibodies with fluorescence or enzyme-linked immunoassay tests, which have provided disparaging results for the detection of B. henselae infections. 11 These issues are the result of the lack of a consistent standard course of anti-B. henselae IgG and IgM production in CSD infections. Some hosts produced high levels of IgG and IgM, some produced only IgM, and a few produced only low levels of antibodies. 4 More recently, polymerase chain reaction (PCR) amplification of DNA from affected tissues for the detection and identification of CSD causative species has been undertaken with some success. Although different genes have been used for the PCR detection of various Bartonella species, most studies have focused on the 16S ribosomal RNA (rRNA) gene. 3 Using PCR methods, the sequences of the 16S rRNA gene have been determined for several Bartonella species. 5, 6, 9, 10, 17 The existence of different genotypes of B. henselae has been demonstrated by the presence of sequence variations in 16S rRNA gene variable regions. 5 Referred to as type I and type II B. henselae genotypes, these sequence differences may represent different pathogenic strains. 5, 16 PCR-based analyses using these sequence differences has demonstrated the presence of both B. henselae genotypes in infected cats and in hu- mans. 16, 17 Similar PCR approaches have been reported for the detection of B. henselae and other CSD-associated species. 2, 15 The successful use of combined PCR and enzyme immunoassay for the detection of B. henselae and B. quintana has also been reported. 15 In the interest of developing a PCR-based assay with an internal standard for the detection and identification of CSD-causative B. henselae strains and other Bartonella species, the present work was undertaken. The results presented here describe a straightforward and very sensitive diagnostic test for routine detection and identification of these microbial species in feline, canine, or human tissues based on PCR and nested PCR amplification of 16S rRNA gene sequences. 13 Bacterial genomic DNA was prepared from pure cultures using commercial DNA isolation kits and the manufacturer's recommended procedures. 6 Clinical specimens. Peripheral blood specimens were obtained from cats infected experimentally with a specific B. henselae strain during an animal study at the School of Veterinary Medicine, Louisiana State University (Baton Rouge, LA). 13 Blood was collected from a jugular vein with 10-ml syringe and a 21-gauge needle in vacutubes containing ethylendiamine tetraacetic acid (EDTA). Tissues were collected from the cats at necropsy.
Materials and methods
Genomic DNA was prepared from cat tissues using commercial kits and the manufacturer's recommended protocol for blood and body fluids. c Enzymes. The Taq polymerase AmpliTaq Gold was purchased from a commercial source. d Enzymes for the LCR amplification, Taq DNA ligase, and T4 polynucleotide kinase for end labeling were purchased from a commercial source. e Oligonucleotides and radioactive isotopes. The relative placement of the effective primer sets and their amplification product sizes are displayed in Fig. 1 . The locations of variable sequence regions for the PCR primer choices were determined by alignment of reported 16S rRNA gene sequenc- es for several Bartonella species and other microbes, which was performed using commercial software f as previously described. 19 PCR and LCR primers were chosen with the aid of commercial primer analysis software g as previously described 19 and were purchased custom-made from a commercial source. h The sequences of the PCR primers and the experimentally determined optimal annealing temperatures for primer sets are displayed in Tables 2 and 3 . The LCR primer sequences are displayed in Table 4 . [␥-32 P] ATP Redivue was used for radioactive labeling. i PCR amplification procedures. The PCR reactions were standardized on a 9600 Thermal-Cycler d using 100 ng of DNA in a total volume of 50 l containing 2.5 units AmpliTaq Gold, 1.75 mM MgCl 2 , 200 M dNTPs, and 1 mM of each PCR primer in the supplier's recommended buffer. A 10-min incubation at 96 C for activation of AmpliTaq Gold was used at the beginning of every PCR. Amplification was performed by 30 cycles of denaturing at 96 C for 1 min, annealing at the appropriate temperature ( Table 2 ) for 1 min, and extention at 72 C for 1 min, followed by a 10-min extension at 72 C and a 10 C soak.
Multiplex PCR was performed for the initial test PCR, except that the universal forward primer (UB16SC3) was added after the 10th amplification cycle. This protocol was designed to ensure ample PCR product for detection and use in the nested PCR tests and to provide an internal standard.
Nested and heminested PCR was performed by the same amplification procedures as described above but with only 20 cycles and 1 l of the initial PCR product.
The PCR products were resolved in 2% agarose (3:1 Nuseive : Seakem) j minigels following 45 min of electrophoresis at 99 V. The PCR fragments were detected by ethidium bromide staining, and the gels photographed with ultraviolet light. The 1-kb ladder and mass ladder electrophoresis molecular weight standards were purchased from a commercial source. j LCR and detection procedures. These LCR procedures have been described previously. 20, 21 One microliter of the PCR or nested PCR solution was subjected to 30 cycles of LCR amplification using 10-15 U Taq DNA ligase in the presence of ϳ500,000 cpm of 32 P end-labeled invariant primers, 1 M of each wild-type or each mutant discriminating primer (or a mixture of all primers, each at 1 M concentration), and 4 g sheared Salmon sperm DNA (or sheared Micrococcal lysideikticus DNA) in a total volume of 10 l containing 20 mM Tris-HCl (pH 7.6), 100 mM KCl, 10 mM MgCl 2 , 1 mM EDTA, 10 mM dithiothreitol, 1 mM NAD ϩ , and 0.1% Triton X-100. 20, 21 The amplification process was a 2-cycle reaction using 94ЊC for denaturation and 65ЊC for ligation. The resulting ligation products were resolved on a 7 M urea, 10% polyacrylamide sequencing gel. The gel was dried and exposed to X-ray film. Sequencing analysis. The sequences of the assay products from selected samples were verified by sequencing. The PCR was performed using the FF/BBR primer set (Tables 1-2) for 30 cycles with genomic DNA isolates of pure cultures and blood specimens from infected cats. The PCR product was then purified to remove reagents and genomic DNA using commercial kits c and submitted for sequencing to the Louisiana State University Genelab (School of Veterinary Medicine, Baton Rouge, LA).
Results
In the interest of determining species-specific sequence differences that could be utilized to develop primers, an alignment of the 16S rRNA gene from a variety of microbial species, including the pertinent Bartonella species, several common pathogenic species, and the reference Escherichia coli, was performed. The region of this alignment containing the highest variability in the Bartonella species is displayed in Fig. 2 . Based on this 16S rRNA gene sequence alignment, primers specific for Bartonella were chosen from variable regions. Primers Bhen16SFF and Bhen16SBBR were found to selectively amplify Bartonella among a number of other pathogenic microbial species (Tables 2, 3 ). The initial multiplex PCR experimental trials using the Bhen16SFF and Bhen16SBBR primer set simultaneously with the previously reported universal primer set, UB16SC3 and UB16SDR9, demonstrated amplicon competition (data not shown). 19 The Bhen16SFF and UB16SDR9 primers displayed a higher efficiency than the other primer combinations in the multiplex PCR experiments. Thus, in the interests of providing an internal standard for verification that negative results would not be due to a failed PCR, a 2-step amplification procedure was developed. Initially, the Bhen16SFF and UB16SDR9 primer set was used in the PCR for 10 cycles, the UB16SC3 primer was added, and the reaction was allowed to continue for a total of 30 cycles (Fig. 3 ). The Bhen16SFF and UB16SDR9 set provided the appropriate 823-bp band for all 4 strains of B. henselae, B. quintana, and B. clarridgeae but not for B. elizabethae or any of the other microbes tested ( Fig. 3 ), although the universal 162-bp band was observable in all DNA samples tested. This species specificity was maintained when a subsequent heminested PCR was performed with Bhen16SFF and Bhen16SBBR, providing the appropriate 567-bp band only in the B. henselae, B. quintana, and B. clarridgeae samples (data not shown).
The amplicon produced by BhenS16FF and Bhen16SBBR was used to determine the sequence of this region for B. henselae strains LSU 16 and LSU Baby. The sequences reported for B. henselae strains 87-66 and Houston-1 and B. clarridgeae were also verified by sequencing of this amplicon (data not shown). The alignment of these sequences of the B. henselae strains, B. quintana, B. clarridgeae, and B. elizabethae enabled the determination of B. henselae strain-specific primer sets from the highly variable region observed at nucleotide positions 181-203 in the E. coli reference sequence (Fig. 2) . Bartonella henselae 87-66 and Houston-1 are identical in this region and have been referred to as the type I B. henselae genotype, whereas B. henselae LSU 16 and LSU Baby have the type II genotype. 15 Three separate primers were developed from this genotype-defining region: Bhen16SGG, Bhen16SHH, and Bhen16SCC specific for B. henselae type I and type II strains and B. clarridgeae, respectively (Tables 2,3). Nested PCR was performed using the PCR product from Bhen16SFF and UB16SDR9. The type I genotype-specific B. henselae primer Bhen16SGG coupled with Bhen16SBBR amplified the appropriate 477bp fragment in the type I B. henselae strains 87-66 and Houston-1 but not in B. henselae strains LSU 16 and LSU Baby or in B. clarridgeae (Fig. 4 ). 16S rRNA PCR for Bartonella Similarily, the type II genotype-specific B. henselae primer Bhen16SHH coupled with Bhen16SBBR amplified the appropriate 477-bp fragment in the type II B. henselae strains LSU 16 and LSU Baby but not in B. henselae strains 87-66 and Houston-1 or in B. clarridgeae (Fig. 5 ). Only B. clarridgeae had the appropriate 477-bp band for species-specific primer Bhen16SCC (Fig. 6 ).
Similar to PCR, LCR is also a DNA sequence amplification technique. However, LCR procedures can determine the identity of a chosen single nucleotide, so that resultant LCR product band sizes are dependent upon whether the nucleotide is adenine (A), thymine (T), cytosine (C), or guanine (G). By choosing a nucleotide within a highly variable region of the 16S rRNA gene where specific species of interest have distinct sequence variations, LCR primers can be de-signed to amplify only the sequence containing an A at the chosen nucleotide site (Fig. 7) . Discriminating LCR primers of different sizes are designed to amplify the same sequence when a T or C (or G) is present in the chosen location ( Fig. 7) .
To establish a routine verification assay for PCR test results using the Bhen16SFF and UB16SDR9 (or Bhen16SBBR) primer set, LCR primers were designed for B. henselae type I and type II. Because of the lack of variability among these B. henselae strains within the 16S rRNA gene sequence, the same location as the priming end of the Bhen16SGG and Bhen16SHH primers was chosen for LCR analyses. Base site 165 of the B. henselae type I sequence was the focus for the LCR design because the power of LCR localizes to a single base while relying on the local sequence specificity (Fig. 7A) . 20, 21 Some variability in the base at site 165 was noted in reported sequences, so that designs were developed for an A, T, and C in this location. The chosen base site for the LCR design for B. henselae type II sequence was the A at site 164 (Fig. 7B) . The LCR design included a T for this site because of the possibility of related sequences.
The LCR multiplex analyses (containing all 6 discriminating primers) demonstrated positive 60-bp and 64-bp bands for only B. henselae 87-66 and Houston-1, both type I strains (Fig. 8) . No bands were observed for either T or C, except with the appropriate oligonucleotide template standard. If too much singlestranded template is present in the LCR reaction, only a single band will be displayed, as was observed in the LCR analysis of oligonucleotide standard containing a C at this site. 20, 21 One picomole of sense strand oligonucleotide template standard containing a T at this site provided both the 61-bp and the 57-bp bands, although the 57-bp band was weak (Fig. 8) . Alternatively, the LCR multiplex analysis of B. henselae type II strains provided positive 56-bp and 63-bp bands only for B. henselae LSU 16 and Baby (Fig. 9) .
These procedures provide a clear diagnostic method for testing for CSD, as best displayed in the sequential analyses of blood specimens obtained from control and infected cats. Specimens were obtained from an ongoing animal study. Several protocols for DNA preparation were not optimal for the isolation and extraction of minute amounts bacterial DNA from an overabundance of host DNA. Several protocols were considered and tested, and the simplest technique providing the necessary sensitivity was provided as a commercial kit. c Specimens were obtained from cats infected with B. henselae 87-66 (Cat L2), B. henselae LSU 16 (Cat 361), Table 4 ). The invariant LCR primers were end-labeled with 32 P prior to amplification. LCR reactions contained all 6 discriminating primers to provide 60-bp and 64-bp, 57-bp and 61-bp, and 54-bp and 58-bp fragments for the sense and the antisense DNA strands for A, T, and C, respectively (Fig. 7A) . Film was exposed for 30 minutes. (Table 4 ); lane 11: 1 pmole of oligonucleotide template standard Bhen16Ss165TLstd (Table  4 ). and controls (Cat 269). These cat tissue specimen DNA samples were assayed by the PCR procedures described above (Fig. 10) . Initially, 100 ng of DNA was amplified with Bhen16SFF and UB16SDR9 for 10 cycles, followed by the addition of UB16SC3 and amplification for 20 more cycles, to provide both the Bartonella-specific 823-bp band and the universal 162-bp band. All 3 specimens displayed the universal 162-bp band, but only the B. henselae-infected cats (Cat L2 and Cat 361) provided the 823-bp band (Fig. 10A ). The control specimen (Cat 269) did not display a 567-bp band for the nested Bhen16SFF and Bhen16SBBR PCR, but Cat L2 and Cat 361 matched positive control samples with a 567-bp band (Fig. 10A ). The subsequent nested PCR for B. henselae type I (Bhen16SGG and Bhen16SBBR) and type II (Bhen16SHH and Bhen16SBBR) provided only positive 477-bp band results for the appropriate cat specimens: Cat L2 for type I and Cat 361 for type II (Fig.  10B ). LCR analyses of cat blood specimens were also consistent with these results (data not shown). The sample sequences of the Bhen16SFF and Bhen16SBBR primer set assays were verified by sequencing (data not shown). Simultaneous cultures of these same cat periph-eral blood specimens were performed with the determination of colony-forming units, and nested PCR was more sensitive than culture for detection of B. henselae infection.
Discussion
An accurate and sensitive diagnostic test for CSD has been developed using oligonucleotide PCR primers that are genus, species, and strain specific. These primers were designed from the variable regions of 16S rRNA gene of the different Bartonella strains and species. A multiplex PCR with the Bhen16SFF Bartonella genus-specific primers and the universal primer set UB16SC3 and UB16SDR9, with the UB16SC3 added after the first 10 cycles, provides an efficient and effective detection assay for Bartonella, with the exception of B. elizabethae. This multiplex PCR amplification using both Bartonella genus-specific primers for the accurate detection of Bartonella (823-bp band) and universal primers as an internal positive control (162-bp band) within each reaction tube permits an inclusive assay with greater assurance of negative results. 16S rRNA PCR for Bartonella Table 4 ). The invariant LCR primers were end-labeled with 32 P prior to amplification. LCR reactions contained all 4 discriminating primers to provide 56-bp and 63-bp, and 58-bp and 61-bp fragments for the sense and the antisense DNA strands for A and T, respectively (Fig. 7B) . Film was exposed for 30 minutes. Lanes 1 and 12: 1 pmole of oligonucleotide template standard Bhen16Ss164ALstd (Table 4) (Table 4 ).
This initial multiplex assay can be followed subsequently by a nested PCR test for enhanced sensitivity and further classification by Bartonella species or strain. Primer designs have also enabled further classification of CSD-causing agents. Exploiting minor sequence differences in the 16S rRNA gene, primer sets have been developed to separately identify B. clarridgeae, B. henselae type I, and B. henselae type II. These variable sites are within the fragment amplified by the Bartonella genus-specific primers, facilitating the nested reaction. All 3 nested PCR strain-specific primer sets utilize the same reverse primer, Bhen16SBBR, and amplify a 477-bp fragment. Only the forward primer is different for each strain, varying by 3 or 4 bases on the 3Ј end.
The sensitivity of these assays was substantially improved when nested PCR was incorporated as a result of increasing the cycle number to 50 while maintaining the microbial species specificity and reducing the required amount of specimen DNA and possible PCR inhibitors. Without the implementation of the nested protocol, the assay sensitivity was below that of bacterial culture. The nested PCR protocol provides dis-tinction between the B. henselae strains and B. clarridgeae and significantly enhances the detection sensitivity. The accuracy and detection capabilities of these assay procedures were demonstrated in the analyses of blood specimens obtained from cats infected experimentally with specific B. henselae strains. Subsequent analyses with the nested PCR procedures has demonstrated a detection sensitivity greater than that of bacterial cultures, especially during the quiescent phase of B. henselae infection in cats.
The large number of microbial 16S rRNA gene sequences available in GenBank have encouraged species-specific PCR-based assays. With both highly variable and highly conserved regions, this gene provides an optimal target for distinguishing between species. The possibility of obtaining a positive Bartonella result in animal or human specimens in the absence of a CSD-causative agent cannot be absolutely ruled out because the 16S rRNA gene has not been sequenced in every bacterial species present in the environment or in mammalian tissues. The 16S rRNA gene is often present in multiple copies per bacterial cell, enhancing the detection sensitivity. An enhancement of this assay may be the use of reverse transcription PCR (RT-PCR) because every ribosome in the bacterial cell would be the target. The shorter half-life of RNA compared with DNA after the death of the cell would enable such an RT-PCR test to provide a distinction between live active Bartonella cells and cellular remnants. These advantages could only be accommodated where both forward and reverse primers are contained within the rRNA gene sequence expressed in the transcribed product present in the ribosome.
These PCR assay procedures were further validated with both sequencing and LCR analyses. LCR also demonstrated sequence differences between B. henselae type I and B. henselae type II. The LCR technique is designed to be sensitive to single base changes at a chosen location but also provides some verification of the local sequence. 19 LCR procedures are more complex but can be adapted for routine analyses, especially with the use of fluorescent chromophores for detection instead of a radioisotope label. 8 The nested PCR assay is a powerful tool for the detection and identification of CSD-causative bacterial agents in biological specimens. These procedures can distinguish between B. clarridgeae and B. henselae and between type I and type II B. henselae strains. This test has become a standard protocol for diagnosis of CSD in at least 1 diagnostic service laboratory for veterinary medicine. The present study also demonstrated that B. henselae LSU 16 and B. henselae LSU Baby are of the type II genotype, identical to GenBank sequence Accession No. AJ223779. These two strains were isolated, cultured, and developed at LSU in the Microbiology Diagnostic Laboratory.
